Filing Details

Accession Number:
0001140361-15-014543
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-04-06 17:00:13
Reporting Period:
2015-04-02
Filing Date:
2015-04-06
Accepted Time:
2015-04-06 17:00:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1213037 Trovagene Inc. TROV Biological Products, (No Disgnostic Substances) (2836) 043721895
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1166309 Bridger Management, Llc 90 Park Avenue
40Th Floor
New York NY 10016
No No Yes No
1258394 Roberto Mignone 90 Park Avenue
40Th Floor
New York NY 10016
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.0001 Par Value Per Share Acquisiton 2015-04-02 300,000 $6.90 3,150,587 No 4 P Indirect See footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnotes
Footnotes
  1. The shares of Common Stock, $.0001 par value per share (the "Shares"), reported herein as indirectly beneficially owned by the Reporting Persons are held of record by Swiftcurrent Partners, L.P., Swiftcurrent Offshore Master Ltd. and Bridger Healthcare Ltd. Bridger Management LLC is the investment adviser to Swiftcurrent Partners L.P., Swiftcurrent Offshore Master Ltd., and Bridger Healthcare Ltd., and as such, may be deemed to share beneficial ownership of the Shares. Roberto Mignone is the managing member of Bridger Management, LLC.
  2. Each reporting person and entity named herein disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein and this report shall not be deemed an admission that the reporting person or any entity named herein is the beneficial owner of the securities for purposes of Section 16, or for any other purpose.